Marijuana-Infused Wine Is Here For Real, Where To Buy?

marijuana-grow-near-albany-for-states-legal-medical-marijuana-dispensariesMarijuana-infused wine is available on very limited stores.
(Photo : Drew Angerer/Getty Images)
First Posted: Oct 17, 2016 05:14 AM EDT
The controversy regarding marijuana is endless. Pro-marijuana people would love to share with others the good effects of the medical cannabis. Marijuana products such as brownies, cannabis oil and so much more flying in. Thus, a new product is made for wine and marijuana fans. The marijuana-infused wine is made available, but people can only buy it in California.

The idea of marijuana-infused wine all started when two girls met on a camping trip in Yosemite National Park in 2010. Lisa Molyneux, a cancer survivor who now owns a dispensary in Santa Cruz and a marijuana retail worked hand in hand with Louisa Sawyer Lindquist of Verdad Wines in Santa Maria. They both want to aid cancer survivors with marijuana and wine.

The result of their brilliant minds is Canna Vine, a high-end marijuana product incorporated with organically grown marijuana and biodynamically farmed grapes, made with the care of Opus One. Celebrities including Melissa Etheridge and Chelsea Handler expressed their support with the marijuana-infused product. As a matter of fact, Etheridge has her own line of wine called Know Label and it was also made by Molyneux.

The catch of the “Pot wine, also known as green wine (described, for legal reasons, as a “tincture”) has probably been around almost as long as there has been pot and wine. Now, the challenge is how to actually get it. Not only it is pricey with a price ranging from $120 to $400 a half bottle. People can buy it only in California, U.S. because it is only legal to buy it there. As for some states where marijuana is also legal such as Colorado, Oregon, and Washington, the problem is it is illegal to infuse alcohol with it, as reported by Indian Express.


However, Sawyer-Lindquist id that “Cannabis wine has been so effective as a stress reliever, as a mood elevator, and as a medicine. I have no idea what the market will be like for it, but whatever I make it I want to be safe, made from pure ingredients and, hopefully, delicious.” Etheridge added that “I think that an herb-infused wine might be the sort of beautiful bridge to helps us to understand where cannabis fits into our culture.” According to LA Times.


Four Years After Legal Weed, Seattle’s Black Market Still Thrives

web1_copy_160914-sea-cvrwebMeet the dealers, buyers, and patients ducking the 502 shops.

  •  Wed Sep 21st, 2016 1:30amWhen I first met Steven, it was in the wee hours at a downtown hotel. The small afterparty he was hosting was in celebration of a successful deal—a very successful one: He’d just connected an out-of-state buyer with 25 pounds of pot—for $35,000 or so—meaning he’d be seeing a significant finder’s fee, perhaps 10 percent. The next day he’d be waking at the crack of noon (or, if we’re honest, 2 p.m.) to head to Oregon in search of more product for his mystery buyer, but for the time being he and his boys were cracking Stellas and cavorting in the hot tub, reveling in the moment.Steven is what can best be described as a broker, someone who connects illicit growers with higher-level dealers looking to buy in quantity. “I’m like a concierge,” he told me. “I take [buyers] out to dinner, make sure they have a good time.” After food and some drinks, he hooks them up with local suppliers, lets them make their exchange, and waits for his fee.

    In Washington, getting rid of people like Steven and his clients was one of the major promises of I-502, the ballot measure that made the state the second in the nation to legalize marijuana. But nearly four years after the initiative passed, street dealers and interstate traffickers are still at it, leaving lawmakers and legal-cannabis-industry players alike scratching their heads (and blowing smoke out their ears).

    It’s difficult to determine just how much of the cannabis industry the black market commands. Some groups have tried, including BOTEC Analysis, the state’s go-to research contractor. In a 2015 report, entitled “Estimating the Size of the Medical Cannabis Market in Washington State,” BOTEC put the black market’s share of the total pot pie at about 30 percent, or $1.33 billion. To arrive at this figure, BOTEC started with an existing RAND Corporation study of the state’s overall cannabis market, then subtracted the state’s recreational and medical markets. The remainder, they concluded, was what was left to the illicit market.

    BOTEC itself noted in its report that the true figure could be far higher or lower than its estimate, given the very nature of the black market. That said, few researchers attempting to gauge the black market in Washington have bothered talking to dealers and buyers themselves. To be fair, it’s not as though there’s a stall at Pike Place Market. But it ain’t exactly hidden either. While I wasn’t able to get El Chapo on the phone, I have managed to chat with some of our city’s friendly local black marketeers. Here are their stories.


    Steven’s business is built around a simple fact about legal cannabis grown in Washington and Oregon: Once it’s shipped to states where pot is still illegal, it fetches an exorbitant price—like $3,500 per pound, says Steven, compared to around $1,400 here in Washington.

    Indeed, he says, many of the black-market growers he deals with are actually involved in the 502 industry but, motivated by those jaw-dropping return rates, maintain “side houses” as an extra means of revenue. “A lot of 502 people have a secret house they grow at,” he says. “My guy, he got some contract with [a 502 retail shop]. I think he gets like $250,000 a year or something.” Still, he sells on the side, substantially padding his income.

That said, in considering the intractability of the black market, one cannot overlook local demand. Our state’s legal cannabis businesses would not be nearly as up-in-arms over the black market if it were only serving smokers in other states. But it’s not. “It’s still definitely cheaper,” Steven says. “I would say the price is still $20 an eighth street level if you have a good dealer. If you were going to Uncle Ike’s, it’s still going to be $30 on the low side, and I think the quality isn’t going to be that much different. They’re definitely going to have way more selection, but I think most people are like, ‘For the price, I’d rather just buy from a drug dealer.’ ”

He also notes that, price considerations aside, ease of access is also a big deal. “If you’ve got to drive 15 minutes to 20 minutes through traffic to go to a store, as opposed to your local neighborhood guy, you’re probably still gonna go to that guy,” he says. “More than anything, the competition from the black market would be these gray-area delivery services. It might only be $5 more, but it’s like ‘All right, I can get this shit now.’ That’s a huge part of why the black market will still exist: the convenience factor. It’s the on-demand generation.”


On that note, meet Bart, a local grower and dealer who uses his small basement grow to support his artistic ambitions. He grows about a pound of high-quality indoor pot a month, and sells it in small quantities to a close circle of trusted longtime buyers. Legalization, he says, hasn’t changed much for him, including prices.

“Prices were kind of going down before legalization,” he says. “Ounces were around $200, and now they’re around the $150 range, depending on quality. I charge $160 because I think I deserve it. But that price was pretty much established before legalization. It wasn’t like [legalization] changed it or brought it down.” Reminded that Uncle Ike’s sells ounces for $99, he points out that you can’t unlink the price from the product itself, suggesting that those $99 ounces are nowhere near his product in quality. “If the price meets the quality in the shops,” he notes, “it’ll be hard to compete with that.”

For now, he has no trouble getting rid of his monthly pound. He even occasionally takes on new clients, though he doesn’t need to to sell out his supply. “If I had my ultimate grow, hypothetically, I’m sure I could start doing, like, pounds a week easy,” he says. “I would just have to be more proactive about it, y’know? Like I kind of stopped doing deliveries. I would have to go back into delivering. I’d probably start talking to other wholesale dealers.” Bart’s experience with delivery neatly illustrates Steven’s point about the power of access. “When I’m not delivering,” Bart says,” I probably lose like 40 percent of my customers.”

Indeed, Jared, a former black-market grower turned regular old black-market customer, says delivery was a big part of why he’s continued to buy from the black market. Price is a factor—the “homie hook-up” prices Jared quotes are, quite frankly, insane: $70 an ounce and $30 for a gram of concentrate—but he’s quick to point out that convenience is a major factor. “My first choice is always gonna be my dude,” he says, “because I know it’s gonna be a little cheaper and he will deliver to me. I could be at work, at my door post [he does club security], and he’ll deliver it to me.” He notes that one of the few reasons he’s had to visit a recreational store was when his dealer was over an hour out and he needed weed in a hurry.


Along with price and convenience, another factor pushing people into the black market is Washington’s recent medical-marijuana law, the Cannabis Patient Protection Act (SB 5052).
SB 5052 folded the state’s loosely regulated medical-marijuana system into the recreational one, mandating that the state’s medical dispensaries obtain I-502 licenses or close. Based on that BOTEC report, the state decided to license 222 new retail outlets, theoretically offering those licenses to established players from the medical-marijuana industry to ensure that they continue to meet the needs of their patients.

However, many contend that those 222 licenses represent a small fraction of the total medical-marijuana market, and that many recipients weren’t as interested in serving patients as in taking their money. In July, as the new system went into place, patients cried bloody murder, saying that their trusted suppliers had been ripped away and suggesting that the move would eliminate affordable medicine, forcing sick people to get their green on the black market—and by extension incentivizing those suppliers who didn’t obtain recreational licenses to go back underground.

Suppliers like Maria. She operated a dispensary in western Washington prior to the implementation of SB 5052. After her attempts to get a license failed, Maria gave up on pot, at least publicly. However, I recently attended an “Ice Cream Social” at her former storefront, now converted to something of a hangout for her patients.

As a bunch of friendly suburbanites—some of whom brought their kids—passed around infused brownies a la mode, Maria stepped frequently into her office for what she called “the other party”: providing the rest of her inventory to patients desperately seeking cheap medicine. One older gentleman, arriving early, made small talk with Maria, then got right to the point. He didn’t need any ice cream.

“So when should I come back?” he asked. Another, upon arriving, cupped a hand over his mouth and asked, “Where’s the product?” Though the scene was aggressively tame, this was technically a black-market deal. One patient picked up what in a retail store would have been $380 worth of flowers, kief, and edibles. Maria hooked him up for $180.
Trent said he bought all his weed on the black market since the new law passed. “What are we to do?” he asked. “It’s inhumane for anyone to deny us anything that medically benefits us.” He’d tried the rec store, he said, but they didn’t have the right strains and the prices were way too high. Maria, however, still had some of the particular high-THC indica that worked to calm his PTSD without putting him to sleep.

And that, more than money, was what drove Maria to host her polite little party. “There’s nothing out there for patients, there’s nothing on the shelves [at the recreational stores],” she complains. “There’s a lot of risk right now, but I’m willing to take that risk because patients need their medicine.”


So if eradicating the black market—at least locally—is a desired outcome of legal cannabis, how does one untangle this ball of Christmas lights? According to Beau Whitney, who runs the cannabis-industry consulting firm Whitney Economics, the answer is reducing regulation. Doing so, he contends, will allow cannabis businesses the necessary flexibility to fill the slots the black market is currently filling.

Essentially, if the legal industry meets the needs of the black market’s varied clientele—the ones who want good, cheap weed; the cancer patients seeking affordable medicine; the guy too lazy to get off his couch and go to the store—there’s no need for a black market. Of all those needs, says Whitney, price is key. “If you bring the price of retail cannabis more in line with the street price, it’ll make a huge dent into the black-market activities,” he says. Whitney has a stake in an Oregon cannabis producer and retailer, and says that at one point they offered a loss-leader special to win over new customers.

“We heard from black marketeers that they were pissed off at our pricing because we were competing directly with them,” he says. “Word on the street was that we had made a big dent. Because of the price sensitivity, we saw a surge in demand at our dispensary.”

Whitney notes that a larger black market means more cannabis arrests and a statistically larger impact on communities of color, as they tend to be arrested for cannabis crimes at a disproportionate rate (though said crimes are committed with the same frequency by white people). “This is not something that can just be ignored by the legislature, this is a public-safety issue,” he says. “There’s all sorts of social costs that are incurred as a result. Increased law-enforcement costs, increased incarceration. It’s typically skewed more towards minorities. There’s a huge social cost to this; it’s hard to quantify, but it’s significant.”


That said, in Seattle there hasn’t exactly been a harsh crackdown on the black market. You can still buy a dime bag in the Jack in the Box parking lot on The Ave, and no one has kicked down Bart’s basement door just yet. Sgt. Sean Whitcomb, the Seattle Police Department’s spokesperson, says that is likely because the department’s primary focus is elsewhere. “There’s three areas where we’re not going to compromise [on pot]: selling to kids, for one; big-profit growing, for two; and driving under the influence,” he says. “If you’re engaged in that activity, don’t think that just because the laws have changed that we’re going to prioritize those any less. We’re very motivated to ensure that those laws aren’t broken.”

However, your average street dealer, provided he or she supplies only grown-ups, has little to fear. To wit, Whitcomb was walking to a bus stop one night when he himself was propositioned with pot. “I said ‘No, thanks,’ ” he tells me. “He was like, ‘No, man, listen, it’s a great price.’ I said, ‘Listen, I’m a police officer, and you’re not allowed to be selling marijuana, that’s a fact.’ He says to me, ‘Well, it’s legal here, man!’ ”

Statistics show an overall reduction in cannabis arrests in legal states, though the racial disparities among those arrests are still stark. However, that doesn’t mean there’s not still risk for black marketeers. For one, homegrows are still an action item in certain circumstances, according to Whitcomb. For example, a break-in at a children’s bookstore in North Seattle led police through a hole in the wall to a large indoor marijuana grow.

“The one that we’re truly interested in is the large-scale illegal-grow operations,” says Whitcomb. “Those are still prevalent in Seattle, and we do come across those with a degree of frequency.”


In the last legislative session, State Rep. Christopher Hurst (D-Enumclaw) proposed a bill to lower the excise tax for cannabis to 25 percent. An economic model he assembled in support of his bill estimated that the state would stand to gain a whopping $1.085 billion by lowering the tax. Hurst wasn’t proposing that the state issue new retail licenses, but his plan did call on the state to override any cannabusiness bans and moratoriums implemented by local municipalities, ensuring that no area of the state would provide a legal-cannabis dead zone for black marketeers to flourish in. (Steven did indeed mention that though the black market has no trouble competing here in Seattle, many black-market actors have migrated to areas with no legal pot businesses to profit off the captive audience.)

As Whitney, the economist, noted, lowering taxes during a budget deficit is always a hard sell, and indeed Hurst’s bill ultimately failed. While Hurst’s own analysis suggested lowering taxes would increase state revenue, an independent state analysis suggested otherwise. Hurst’s info sheet for the bill included a plea for fellow legislators to think past the fiscal note, which showed a $43 million loss in tax revenue, but the bill failed.

Defeat aside, though, Whitney says Hurst was on to something. “Once you bring in more people, reduce the taxes, and reduce the regulatory burdens, then you can drive down costs and do massive production,” he concludes. “Then you can drive out the black market because their onesie, twosie production can’t compete on price.”

Steven puts it more directly. There will always be a black market, he says, “until it’s like a pack of cigarettes and you can just walk into the corner store and get it. That’s when drug dealers will finally be gone.”

Baked Baklava

I’m in the mood for some Baklava!  Originally Posted on August 16, 2016 in Desserts, Snacks at Original Weed Recipescannabis_backlava-638x355

Try these delicious and delightfully gooey snacks. They will not only impress your friends but they are sure to come back another time for the kick again. Edibles have never tasted this good!


  • · 1 1/2 pounds Walnuts, Chopped
  • · 2 cups Sugar
  • · 1/2 teaspoon Nutmeg
  • · 3 teaspoons Cinnamon
  • · 3 sticks Canna Butter
  • · 16 ounces Filo Dough
  • · 1 1/2 cup Water
  • · 1 1/2 teaspoon Lemon Juice
  • · 2 cups Honey
  • · 1/2 teaspoon Vanilla

Kitchen Equipment:

  • · Mixing bowl
  • · Baking dish 10×15
  • · Oven
  • · Saucepan
  • · Spoons


Set aside 2 tablespoons of the Canna butter. With the remaining butter grease a 10×15 inch baking dish. Now take 10 sheets of Filo dough, coat each with a good layer of butter and place them in the baking pan. Mix together the walnuts with one cup of sugar and pour this evenly into the pan over the Filo dough sheets. Now take another five layers of Filo dough, butter them and then place them in the pan as well. Preheat oven to 300°F and bake the dough for 50 minutes. While this is baking take a saucepan mix the leftover sugar with the spices, vanilla, water, lemon and cook till the mixture is syrupy. Add honey and heat for a minute. Remove from heat. Cut the baklava into 2 inches by 2 inches squares or any other shape you want and then pour the syrup over them. Now, have patience- set aside for two days so as to allow the honey to permeate. You are now ready for the spicy Canna treat.

Portland startup Phylos Bioscience raises funds to bring a scientific approach to the cannabis industry


The Phylos Galaxy, an interactive genetic map of cannabis strains, was the result of collaboration between Phylos Bioscience and the American Museum of Natural History. (Click for interactive graphic)

When Mowgli Holmes moved back to his home state of Oregon in 2013, the cannabis industry was beginning to take off in a big way — but as a molecular and evolutionary biologist, Holmes was surprised by the lack of research into cannabis as an agricultural plant.

“This new industry was taking shape really rapidly all around me, and it had no science driving it,” Holmes said. “All the basic science that we have for every other crop just doesn’t exist, and people are just running with zero knowledge.”

Holmes and co-founder Nishan Karassik started PhylosBioscience in 2014 to fill that gap in understanding. A new investment round will help the company expand its infrastructure in support of a new phase in its development. Phylos has raised $1.4 million of a planned $5.5 million round, according to a Securities and Exchange Commission filing.

“We’re going to be getting an Oregon State cannabis research license, and starting to do the basic genetics research that will help breeders develop new plant varieties,” Holmes said.

Phylos has spent the last two years developing tools to help cannabis breeders and growers learn about the genetics of their crop, including the Phylos Genotype, a tool that catalogs the DNA of  individual plants. Holmes said a commercial version of the tool is planned for release in two weeks.

The startup also partnered with the American Museum of Natural History on the Cannabis Evolution Project, a two-year research project which tested the DNA of thousands of cannabis samples to produce an evolutionary map of the crop. The project also resulted in the Phylos Galaxy, an interactive visualization of the data, including the genetic relationship between cannabis strains.

“We tried to make it so that the basic visualization of the genetic structure of the population would be interactive, so people could play with it and zoom around in it and learn from it,” Holmes said.

Holmes also pointed out that, unlike in many agricultural industries, genetic information can be as valuable and interesting to a consumer as it is to growers and breeders. Holmes now serves as Phylos Bioscience’s chief science officer, and Karassik as its CEO. The startup employs 15 people at its headquarters in downtown Portland.

Oregon Cannabis Industry Facing Regulatory Uncertainty


New Challengs Face Oregon Cannabis Industry.

By Cynthia Salarizadeh

The Oregon Cannabis Industry is facing both double regulations, and regulatory Uncertainty. While seed-to-sale regulations are becoming the accepted norm in all states which have decriminalized cannabis, the situation in Oregon presents new challenges for industry dispensaries and growers.

That’s because Oregon is regulated by two separate agencies that have control over seed-to-sale and the traceability and packaging of cannabis: the Oregon Liquor Control Commission (OLCC) that oversees recreational sales and the Oregon Health Authority (OHA) that overseas medicinal products.

The reason for the two oversight agencies has to do with timing: recreation was approved first October 2015 when the Oregon Liquor Control Commission approved a set of extensive regulations designed to create a viable, profitable and accountable recreational marijuana industry. The first licensed recreational dispensaries are expected to open in December 2016, while, medicinal products were approved by the Oregon Medical Marijuana Act in November 1998.

To accommodate both medical and recreational dispensaries, Oregon regulators had to make some innovative changes that allowed licensed medical marijuana stores to continue to sell recreational marijuana products, but only until Dec. 31, 2015. Then, on Jan. 1, 2017, medical stores will no longer be able to conduct recreational sales since the new recreational dispensaries will be open for business.

As part of these new regulations, the OLCC created a comprehensive tracking system that covers the entire cycle of cannabis planting, cultivation, processing and ultimate sale to individuals as part of its seed-to-sale tracking system. This covered every aspect of the industry from laboratories, processors, wholesalers, and retailers. The system became effective in January 2016 to coincide with the acceptance of the first state licenses for licensed dispensaries to sell to cannabis recreation users.

Under Oregon law, medical grow sites started their registration process on March 1, 2016. This process mandated that licensed dispensaries produce monthly reports to the OHA on what is cultivated, possessed and distributed to patients and dispensaries.

In practice, this means that effective in June 2016, dispensaries had to adhere to the Administrative rules (found at Oregon Administrative Rules 333-008-0000), which include the following:

On a monthly basis, and no later than by the 10th day of every month, “a person designated to produce marijuana by a patient must submit the following information to the Authority”:

  • The number of mature marijuana plants and immature marijuana plants, the amount of marijuana leaves and flowers being dried, and the amount of usable marijuana, in the person’s possession;
  • The number of mature marijuana plants and immature marijuana plants, and the amount of usable marijuana transferred to each patient for whom the person produces marijuana, or that patient’s designated primary caregiver during the previous month;
  • The amount of usable marijuana transferred to each marijuana processing site during the previous month;
  • The number of immature marijuana plants, and the amount of usable marijuana transferred to each medical marijuana dispensary during the previous month.

All of this information must then be submitted electronically and “a person designated to produce marijuana by a patient must keep a record of the information for two years after the date on which the person submits the information to the Authority.

Integrated Software Makes Compliance Easier

Depending on the type of dispensary operation (medical or recreation), Oregon cannabis operations are working in a constantly changing regulatory environment.

For example, according to CJ Stechschultes of Growing ReLeaf medical dispensary in Beaverton, Oregon, even though the OLCC has no jurisdiction over its operations, the company has applied for its OLCC license. While Stechschultes said the business is “currently up-to-date with the latest required rules which, luckily, overlap with OHA’s,” seed-to-sale regs are not affecting them for another three months. “However, we are currently taking the necessary steps to be prepared for this in the future by getting familiar with the Cannabis Tracking System (CTS) Metric. Furthermore, we have been working with BioTrackTHC as our POS system, which is known for its tracking abilities.” Stechschultes said “this is a volatile time concerning rules and regulations.”

Another Oregon dispensary, which chose not to use its name, said the regulatory bodies in Oregon that either currently or plan to govern marijuana on a state level (both the OLCC and the OHA) “cannot keep up with their own deadlines and regulations. Specifically with the OHA, they are grossly overworked and understaffed and are not empowered in the proper way to enforce the regulations in a productive or efficient manner. This is a point we have been frustrated with in the past due to competitors knowingly operating outside of these regs and not having any kind of retribution, while we follow all regs and suffer retribution from our customers because of it.”

The Benefit of Good Tracking Software

Companies such as Biotrack THC, based in Ft. Lauderdale, Fla., have developed the software that lets state governments monitor the entire process of legal cannabis production and sales, including its testing, transportation, destruction and sales.

This means states can follow a dispensary’s inventory and the taxable sales in real time and makes for more accurate revenue collections, while making legal cannabis growers and dispensaries accountable for their inventories.

According to Alen Nguyen of MainStem, the Biotrack software helps the OLCC by providing an inventory control system that tracks cannabis cultivation and movement and the cultivation site and accounts for all legal products, while keeping black market products outside of the regulated system. This oversight also applies to packaging. All Oregon cannabis products, including everything manufactured by MainsStem, come in a child resistant package, he said.

This benefits the public since it assures safety standards are met and allows authorities to track any bad product back to its original source. “All Growers really need to take traceability into account within their growing process,” Nguyen said.

Using a very similar system that the company developed first to track pharmaceuticals, the Biotrack software system allows the state of Oregon, for instance, to track each gram of legal cannabis throughout the plant’s entire grow, processing and sales cycle. According to Moe Afaneh, COO of Biotrack THC, the company has successfully integrated its tracking software with recreational and medicinal dispensaries and is working with its several hundred customers in Oregon to make the seamless transition to the two separate regulatory systems.

Oregon’s rigorous standard requires detailed recordkeeping, but new software is helping Oregon dispensaries adhere to these rules. Biotrack software keeps track of everything from inventory management to point-of-sale transactions to individuals to meet both quality assurance and compliance standards.

According to Dan McMahon, Vice President of Government Solutions for Biotrack THC, regulations in Oregon change rapidly, so dispensaries and growers are always being scrutinized. For instance, unlike other perishable commodities, cannabis loses weight and weight as it sits on the shelf. This means dispensaries have to follow the first-in-first-out (FIFO) inventory system because the product is “perishable to the nth degree,” McMahon said. Declining weights also have to be accounted for in the compliance process, he added.

In addition to weight, every batch of the product also has to be tested for pesticides and all products face tough labelling standards.

About the author:

Cynthia Salarizadeh is the Founder and CEO of Salar Communications Group. Her area of expertise centers on public relations and strategic communications. She entered the cannabis industry to solely focus on improving the perception of cannabis for better market conditions through strategic campaigns that sit at the center of the battle for legalization and economic prosperity. Salarizadeh holds a Bachelor’s degree in International Relations with a minor in Modern Middle Eastern Studies and a focus on Strategic Communications from the University of Pennsylvania. She also holds a certificate in Political Journalism with the Fund for American Studies from a program at Georgetown University.

Meet The Chef Who’s Infusing Jewish Food with Cannabis



The “Julia Child of Pot” is reinventing the way Americans cook with cannabis, and adding a Jewish twist. It’s not just “weed butter” and “pot brownies” anymore–it’s “potato latkes with canna-pear creme fresh” and “stoned pepper pecan noodle pudding.”

All of these cannabis-infused Jewish classics and more can be found in The 420 Gourmet: The Elevated Art of Cannabis Cuisine, which hit the shelves in June. The recipes feature fresh produce and seasonal ingredients, fitting right in with other contemporary cookbooks, and drawing on Mediterranean and Mexican flavors.

According to The Forward, cookbook author “JeffThe420Chef” (he doesn’t reveal his real name) rose to fame in San Fransisco last year when he catered his first “Pot Shabbat.” His menu featured fresh vegetables and bright flavors like tamarind brussels sprouts and cannabis oil-infused matzah balls.


Jeff was raised in an Orthodox home, and grew up eating plenty of Ashkenazi classics. He got his start while experimenting with ways to make “tasteless” cannabis-infused oils and butters, which are the foundation for the recipes in his cookbook. His goal, then and now, is to help people cook healthy, medicinal meals with marijuana.

Aside from marijuana-laced challah and gefilte fish, he experiments with Middle Eastern-inspired dishes like Spinach and Feta Cana-Borekas, Cana-Lamb Tagine with Cilantro and Mint, Canna-Ganoush, and Candied Eggplant “Bacon.”

Here are a few more Jewish classics from his website:

Potzo Ball Soup
Sea Salted Canna-Caramel Hamantaschen
Canna Avocado Hummus

Cannabis Found to Shield the Brain from Alzheimer’s Disease


Bad news for Alzheimer’s disease: THC (the active chemical compound in marijuana) is officially acknowledged to remove the toxic bundle of amyloid beta protein that onsets the evolution of the disease, ultimately damaging the brain beyond repair.

This late discovery is backed up by previous studies revealing the effective and protective qualities of cannabinoids and THC over patients suffering from this neurodegenerative disease.

Little is known about what exactly causes Alzheimer’ disease, but so far it’s believed to be caused by two types of lesions: neurofibrillary tangles and amyloid plaques. The amyloid plaques form dense groups between the neurons, and the neurofibrillary tangles are produced by defective tau proteins that bundle up into a thick, insoluble mass in neurons.

The biological mechanism behind the formation of these lesions is yet a mystery, but recent studies have linked the inflammation in brain tissue to the spread of amyloid plaques and neurofibrillary tangles.

Inflammation within the brain is a major component of the damage associated with Alzheimer’s disease, but it has always been assumed that this response was coming from immune-like cells in the brain, not the nerve cells themselves,” said Antonio Currais, member of Scripps Research Institute.

When we were able to identify the molecular basis of the inflammatory response to amyloid beta, it became clear that THC-like compounds that the nerve cells make themselves may be involved in protecting the cells from dying,” he concluded.

David Schubert and his colleagues from the Salk Institute for Biological Studies in California, tested the impact of THC over the symptoms of Alzheimer’s disease.

Although other studies have offered evidence that cannabinoids might be neuroprotective against the symptoms of Alzheimer’s, we believe our study is the first to demonstrate that cannabinoids affect both inflammation and amyloid beta accumulation in nerve cells,” said David Schubert.

For those unfamiliar with THC, this compound is responsible for the psychedelic effects and pain relief experienced as a result of smoking or ingesting cannabis buds. It is important to know that cannabis does not offer the state of mind and/or body high if consumed raw, requiring heat to release the THC that gives that unique tingling. Besides all these, most important is THC’s influence over HIV symptoms, chronic pain related to chemotherapy, post-traumatic stress disorder and stroke.

Scientists are so impressed with THC’s therapeutic properties that they initiated a program to breed genetically modified yeast that would yield more THC than any other method of synthesizing the compound.

On the cell surfaces all over our body can be found the CB1 and CB2 cannabinoid receptors that extract the THC directly from the bloodstream, after it passes from the lungs. In the brain, the cannabinoid receptors are found in the neurons associated with time perception, coordination, memory, thinking and pleasure, regularly binding with endocannabinoids, known to be a class of lipid molecules created by our organism during physical activities, in order to stimulate cell-to-cell signaling in the brain.

Due to tetrahydrocannabinol’s tendency to bind to lipid molecues, it interferes with brain’s ability to communicate with itself. This means that you may not be able to fully perform complex physical actitivites, but your state of mind could be at its fullest, compensating one for another.

Since THC is great for removing the harmful accumulations of amyloid beta proteins, this could mean something big for most, if not all the symptoms related to aging. So far, THC has proved itself to be very promising in reducing inflammation and plaque build-up, according to newest lab test results.

However, the government is still getting in the way of progress, despite cannabis’s potential has been clearly proved and confirmed, so the good news are that the researchers have found a backdoor in the form of a new drug called J147 that mimics identically the effects of THC, that will allow conducting further research for the sake of humanity and well-being.

The results of the study can be found HERE.

Woman Rids Body of Cancer in 4 Months Using Cannabis Oil


MEDICALMARIJUANA.CO.UK – News, information and discussion on the medicinal use of cannabis and cannabis extracts.

Woman Rids Body of Cancer in 4 Months Using Cannabis Oil

Medical doctors and healthcare personnel alike are stymied by the miraculous cure which recently occurred to Michelle Aldrich who suffered from a deadly form of lung cancer.

Michelle was sixty-six years old at the time. Initially she developed a low-grade fever and cough which she couldn’t shake. Several months later it worsened; she developed signs of a pneumonia which prompted her to seek medical care. Her doctor ordered a CT scan trying to determine what the problem was. The scan revealed a large mass in the central region of the chest consistent with lung cancer.


Unfortunately the biopsy and staging of the tumor revealed it to be poorly differentiated, non-small cell lung cancer (adenocarcinoma) or NSCLC for short, stage three. All lung cancers carry a poor prognosis but this form is particularly aggressive. From the National Cancer Institute:

General Information About Non-Small Cell Lung Cancer (NSCLC)

NSCLC is any type of epithelial lung cancer other than small cell lung cancer (SCLC). The most common types of NSCLC are squamous cell carcinoma, large cell carcinoma, and adenocarcinoma, but there are several other types that occur less frequently, and all types can occur in unusual histologic variants. Although NSCLCs are associated with cigarette smoke, adenocarcinomas may be found in patients who have never smoked. As a class, NSCLCs are relatively insensitive to chemotherapy and radiation therapy compared with SCLC. Patients with resectable disease may be cured by surgery or surgery followed by chemotherapy. Local control can be achieved with radiation therapy in a large number of patients with unresectable disease, but cure is seen only in a small number of patients. Patients with locally advanced unresectable disease may achieve long-term survival with radiation therapy combined with chemotherapy. Patients with advanced metastatic disease may achieve improved survival and palliation of symptoms with chemotherapy, targeted agents, and other supportive measures.

Incidence and Mortality

Estimated new cases and deaths from lung cancer (NSCLC and SCLC combined) in the United States in 2015 1:

• New cases: 221,200.

• Deaths: 158,040.

Lung cancer is the leading cause of cancer-related mortality in the United States. 2 The 5-year relative survival rate from 1995 to 2001 for patients with lung cancer was 15.7%. The 5-year relative survival rate varies markedly depending on the stage at diagnosis, from 49% to 16% to 2% for patients with local, regional, and distant-stage disease, respectively. 3

Michelle was classified with having stage three or T3, involving a number of regional lymph nodes in the chest. A T4 staging means distant nodes were found to be positive for tumor metastasis. Five-year survival vastly decreases from T3 to T4.

Surgically resectable disease is generally stage I, stage II and selected stage III tumors. Generally T3 and T4 use combination modalities since surgery cannot be used solo for cure. One must also use chemotherapy and or radiation.

But let’s face it, survival for this type of cancer hasn’t improved since the war on cancer began in the seventies as Dr Abramson reminds us. In his pivotal book “Overdosed America,” he explains that the age-adjusted death rate for all cancers has actually increased since the “war” began. Put simply: you are no better off today with most cancers than you were 45 years ago. Unless you have the courage to venture outside the conventional medical “box.”


At best using conventional medicine Michelle had an approximately 49% five year survival and that’s with only local tumor involvement. It drops quickly as you can see from above down to 2% five year survival with distant stage disease.

“I thought I was going to die,” Aldrich says from her Marina District apartment. But she didn’t. And now, she is busy telling anyone who will listen that, along with diet and chemotherapy, a concoction of highly concentrated cannabis oil eliminated her cancer in less than four months. 4

Initially diagnosed in January of 2012 and by April 2013 a repeat CT scan showed a reduction in tumor size by 50%. What tumor remained was surgically removed. Repeat CT scan showed no tumor involvement anywhere in the chest.

Her doctors — one of whom noted the effect of “homeopathic treatments, including hemp oil” to reprogram the cancer cells to kill themselves — “are floored,” she says. “They’ve never seen anything like it.” 5


See how confusing the nomenclature is? To clarify, Michelle did not use “hemp oil” she used cannabis oil which is completely different. Specifically she used Rick Simpson Oil (RSO), AKA Phoenix Tears. It is also not homeopathic in any sense of the word. RSO is allopathic all the way; it acts much like a powerful drug, as powerful as any pharmaceutical. In fact, it appears to be much more effective than any chemotherapeutic currently on the formulary.

Using “hemp oil” which is the essential oil extracted from industrial hemp, to treat ANY disease is a fool’s errand. Only authentic cannabis oil can cure cancers. Please be aware of that fact. Industrial hemp is good for food-grade seeds, its bright green oil can be used in salads. It’s also good for textiles and paper but when you want to cure disease you need the big guns that real cannabis employs.


In the East Bay area of San Francisco where I had my medical practice lives a woman who is very well known to the cancer community. She is a very busy person. While the webpages of the NCI claim that there is no evidence that cannabis cures cancers, we have plenty of real-time and anecdotal case reports of numerous cures of “incurable” late stage, highly aggressive tumors. Some of those reports come from Constance Finley.

Employing the same manufacturing techniques seen on Rick Simpson’s website, she takes a pound of cannabis and reduces it into one ounce of pure medical magic.

This cannabis reduction sauce (essential oil) in its thickened final stage is called Rick Simpson Oil (RSO).

Most oncologists would guffaw over the idea that the sap of a common weed could defy the realm of possibility and outperform the best that Big Pharma can deliver. But it can and it does. The internet is overflowing with anecdotal cures of virtually any cancer regardless of cell type. Doctors and laypersons alike would never believe it was possible were it were not for the scores of bona fide, documented, cases seen by this woman and many others.

She was quoted as saying that there is a world-class oncologist in San Francisco who has already referred 26 “deaths door” patients to her in 2013. All 26 of Finley’s referrals had stage 4 cancers. The patient population included brain tumors, colon cancers, and lung cancers to name a few. Stage four is a death sentence since it means the malignant cells had escaped the primary tumor and metastasized to other organs. Most had only a few months to live, some had less than six weeks. All patients received modern medical treatments such as chemotherapy with the concentrated oil. She reportedly has “cured” all but one of them. That’s a 96% cure rate, the best in the business if it’s true. And it’s not just in San Francisco.

These survival stories are becoming more common. One of the most high-profile was the case of Montana toddler Cash Hyde, diagnosed with a brain tumor at 20 months, whose family credits cannabis oil for keeping the tumor at bay and keeping him alive — until a change in Montana state law cut off his access to oil for a few months. The tumor returned and he died in November, at age four. 6


Understandably this San Francisco oncologist prefers to keep his name private when being quoted. Even when a powerful remedy like this mops up cancer cells like a Pickwickian tween in a pie-eating contest, academics still prefer to remain hidden lest they succumb to the predictable harassment and ridicule of their peers. Some could easily lose their jobs should they become overzealous reporting the truth that a simple plant extract outperforms the best chemo by an unbelievably wide margin.

One question. When will these oncologists start referring patients to Finley before the system nearly kills them? Imagine how helpful it could be then.


Remember also that RSO is NON-TOXIC. There is no devastating blowback from using it. Contrast this to your typical chemotherapy course which causes blood cancers years later in up to 15% of patients who received chemo at some point earlier in their disease course. Furthermore, chemotherapy is an efficient immune system destroyer. Just what you don’t need when fighting for your life.

Meanwhile, by definition late stage cancer is incurable and always leads to 100% mortality. This makes RSO even more astonishing. That’s because these people are written off by modern medicine as failures where nothing could help them. Sick, emaciated from chemo and radiation, cachectic and nearly dead she revives them like a modern day Lazarus factory.

Take a moment to reflect on this humble fact. It reveals to us the absolute beauty of this incredible, health-regenerating, symphony of phytocannabinoids. A true gift from God.

If it’s all true. And that’s a big if. We need controlled studies now more than ever before. But don’t hold your breath. Clinical trials are ten years away, minimum.

To make this unpretentious oil is actually very easy. Simply go to Rick Simpson’s website for instructions. The most important of all is that you use a safe solvent for extraction. Aldrich’s providers use Everclear in making what they call “Milagro oil” which is the same as RSO, at Wo/Men’s Alliance for Medical Marijuana in Santa Cruz, CA. Finley’s operation uses isopropyl alcohol which can be toxic in large doses. Theoretically you will boil off all of the isopropyl alcohol but personally I think it’s far better to use ethanol the only truly safe alcohol (in small doses).

Once they have procured the precious oil patients with end-stage disease need to ramp up to an anti-cancer blood level as soon as humanly possible. But the material is extremely potent: a concentrated extract clocking in at around 70% active THC or higher. The oil is a reduction using heat so all of the acidiccannabinoids are converted to psychoactive decarboxylated forms of which THC is a major component.


But it’s not just the THC that they need. All of the 60 phytocannabinoids, decarboxylated and ingested along with the terpenes, and thousands of other mysterious chemicals found in the oil, produce the “entourage effect.” Scientists have speculated that this synergy is the real reason why RSO is so strangely effective. You need whole plant extracts of real cannabis to knock cancer cells into next week. The potent psychoactivity is the biggest hurdle to overcome.

That’s why patients need to start out with a dose that will not pound them into submission the first day which may discourage its use. Practitioners who use the drug regularly recommend starting out with a small rice grain sample of the sticky oil, rub it inside your mouth along the gum line. After that you simply swallow it. From there you quickly work your way up to dosing four times a day or more. For those familiar with the high of cannabis they can accelerate the dosing very quickly if they like the way they feel. You’ll be doing a lot of sleeping since the preparation normally comes from an indica only species. No sativas are used since the preparation becomes too speedy for most patients especially at high dosages. Sleep induces healing. It’s all part of the process: eat, sleep, relax, protect, and don’t forget…forget.

With perseverance one can increase the dose rapidly to full-strength in one week. You’ll want to increase the dosing of a “rice grain” to four time a day or more to achieve a total of one gram per day. So each dose is about ¼ gram. At that point blood levels are high, we start to see the magical entourage effect take place. Tumors shrink and finally disappear to be replaced with healthy cells.


The cost? At a gram per day one needs to take it until the cancer is gone which is at least four months. A pound of quality (organic) Indica which is what they prefer to use to help you sleep and heal, runs about $2,500 to $3,000 in the Bay Area. Aldrich says a three-month regimen costs her $1,200 a month; Finley charges $5,500 for a two-month cycle. 7 That’s pricey but compared to what?

A typical cancer patient caught in the Commercial Sick Care System (CSCS) could buy a (used) Bentley with the money they need for chemotherapy and radiation. In the US they will on average spend eighty thousand dollars toward chemotherapeutics during the last two years of life and often die in spite of “cutting edge” therapy. When viewed this way cannabis oil looks exceedingly cheap and very worthwhile. With the added bonus-you get to live.

The statistics tell us either you pay eighty thousand over two years for the right to die in pain, anguish, and loss of dignity; or you shell out eleven thousand on RSO and possibly receive a new lease on life. I don’t know that’s a tough choice.

Furthermore, patients with NSCLC who have survived their ordeal often develop secondary lung cancers years later as a matter of course.

Not so with RSO. Taking a lower maintenance dose of RSO after the tumors disappear is highly recommended since it will help prevent the ignoble recurrence of tumors.



  1. American Cancer Society: Cancer Facts and Figures 2015. Atlanta, Ga: American Cancer Society, 2015. ↩
  2. American Cancer Society: Cancer Facts and Figures 2015. Atlanta, Ga: American Cancer Society, 2015. ↩
  3. Ries L, Eisner M, Kosary C, et al., eds.: Cancer Statistics Review, 1975-2002. Bethesda, Md: National Cancer Institute, 2005. ↩
  4. ( 09/22/2015 ↩
  5. IBID ↩
  6. ( 09/24/2015 ↩
  7. IBID ↩

Oregon’s cannabis fair celebrates growing pot industry


Junnelle Hogen, The (Salem, Ore.) Statesman Journal , KHOU 9:34 PM. EST August 14, 2016


(Photo: Molly J. Smith, Statesman Journal)

SALEM, Ore. — Marijuana leaves of all shapes and sizes lined a competition alcove at the Oregon State Fairgrounds on Saturday. The plants were surrounded by hundreds of booths listing technology, agriculture and business innovations in the cannabis growing industry.

“People say we’ve ‘Microsofted’ the cannabis industry,” joked organizer Mary Lou Burton.

The weekend even was the first marijuana growers fair in Oregon, hosted at the Oregon State Fairgrounds in Salem. Sponsored by the state marijuana business council, and with presentations from state agencies regulating the newly legalized industry, it highlighted a number of desires from Oregon entrepreneurs and businesses to turn the state into a go-to region for marijuana.

“It’s no longer a black market. It’s a burgeoning market,” said Caleb Hoffman of Colorado. He said he reserved a hotel room for the weekend to attend the fair, to draw inspiration from state innovators.

Saturday afternoon, the fair also hosted the first cannabis live plant competition in the state, featuring 51 leafy plants. Five judges led by Ed Rosenthal, the styled “guru of ganja” by admirers, picked out nine winners for sativa, hybrid and indica varieties.

Several of the winners came from the outskirts of Salem. Danny Grimm and Nathan Martinez hugged after the winning results, and proudly displayed blue ribbons.

The two men, with the cannabis farm Uplifted, won first in two categories, boasting honed indica and sativa plants.

They say they are planning to switch to pure recreational marijuana grows in a few months, and are signing a lease on a new 50,000-square-foot facility, in place of their local 5,000-foot facility.

“I’ve been growing plants for 12 years,” said Grimm. “It’s basically trial and error. It has molded our company into what it is today.”

Portland winner Daniel DeMeulle, whose stocky offering placed first in the hybrid category, is a home grower. He decided to enter the competition “on a whim,” and has been honing techniques from online tutorials.

“The internet, books, trial and error. That’s about it,” DeMeulle said.

The winning plants will resurface at the fairgrounds for the Oregon State Fair in two weeks. Due to controversy with the 4-H, and concern from parents that their kids might get hold of the leafy plants, they will be featured in a separate greenhouse guarded by volunteers, who will card onlookers, only admitting people ages 21 and older.

The upbeat nature of the fair contrasted with a recent ruling from the federal Drug Enforcement Administration.

On Thursday, the DEA announced it will keep marijuana illegal for any purpose on the federal level, retaining its standing as a Schedule 1 substance under the Controlled Substances Act.

Fair administrators found this was a deterrent before the fair. Because of the illegal federal standing, FCC regulations kept them from advertising the event.

Instead, they put a “mobile billboard” on a car to draw in passersby.

Several growers and organizers said they hoped the federal deterrent might keep the Oregon industry out of the hands of big businesses.

Already, the Oregon Department of Revenue estimates the government will take in $43 million from pot taxes this year.

“We have hurdles to jump through,” said Burton. “But where we’re at right now is our silver lining. We’re going to have a couple more years before the big boys come on board.”


Buyer Beware: Oregon’s First Marijuana Investor Fraud Scandal

Aug 1, 2016 at 4:20 PM

I can’t count the number of times I’ve warned potential investors that the cannabis industry is rife with fraud and bad behavior. With legalized cannabis still a relatively new industry and with states constantly changing their cannabis regulations, fraudsters can have a field day.

Cue the bizarre (though unsurprising) case of Portland-based dispensary,
Cannacea, and allegations of cannabis investor fraud swirling around it.I can’t count the number of times I’vewarned potential investors that the cannabis industry is rife with fraud and bad behavior. With legalized cannabis still a relatively new industry and with states constantly changing their cannabis regulations, fraudsters can have a field day.

Last week, as reported by The Oregonian, “[t]he Oregon Department of Consumer and Business Services [“Department”] ordered Tisha Siler, CEO of a Northeast Portland pot dispensary called Cannacea, to pay $40,000 in fines for multiple violations of state securities law, including selling securities without a license.” You can read the Department’s order against Cannacea and Siler here.

According to the order, in November 2014, Green Rush Consulting, a California cannabis consulting company which “worked with a felon previously convicted in a financial scam,” helped Cannacea and Siler come up with a private placement memorandum for potential investors of Cannacea. The Department found this PPM contained multiple misrepresentations, probably the most egregious of which was that “Oregon regulators contacted and specifically invited Siler to ‘open cannabis dispensaries in Oregon,’ and that ‘Oregon regulators stated they would ‘pre-approve’ or ‘green light’ up to six of Respondents’ medical cannabis dispensary applications, ‘ensuring [Siler] would sail smoothly through the application process.’ This ‘pre-approval’ or ‘green light’ was emphasized repeatedly throughout the PPM. In truth and in fact, no such statements were made by any Oregon regulator.” Out of all of the suspect PPMs the cannabis business lawyers in my firm have seen (which are many), this takes the cake as the most outrageous since no regulatory authority would ever make such a promise to anyone.

The facts get even more interesting:  In connection with the creation of the PPM, Siler provided Green Rush with a letter, dated October 16, 2014, that was purportedly from the Oregon Health Authority Medical Marijuana Dispensary Program (the “MMDP Letter”). The MMDP Letter represented that Cannacea had received a ‘green light’ from MMDP for six dispensary locations. In truth and in fact, the MMDP Letter was a fraudulent document. Specifically, the MMDP Letter: was created on letterhead that is not used by MMDP; contained fabricated statements, and; contained a forged signature of a regulator that did not even work in the MMDP. Upon information and belief, the MMDP Letter was created by Siler, or by another at her direction.

The result from all of this is that Cannacea and Siler cannot do any business in Oregon, and both Cannacea and Siler are jointly and severally responsible for $40,000 worth of civil penalties assessed against them by the Department. And while Green Rush Consulting is allowed to continue its consulting service in the state, Green Rush Consulting is “prohibited from engaging in any business activity related to securities in Oregon without permission from the Department of Consumer and Business Services.”

The foregoing is a cautionary tale for investors, marijuana businesses, and state regulators. Far too often, state regulators are too bogged down with satisfying current federal enforcement priorities to deal with the actual business of marijuana. So, I applaud the State of Oregon for setting an example for other states by actually taking relatively swift action here. As the industry matures in all states that seek to legalize, fraudster companies and at least some “cannabis consultants” will no doubt continue to take advantage of unwitting investors. In turn, state securities regulators should be setting their own guidelines for how to better prevent this kind of fraud. In the meantime, be careful out there and exercise caution when you receive a multimillion-dollar cannabis private placement.


Where the buzz is created….

%d bloggers like this: